Unified promoter opening steps in eukaryotic gene expression
نویسندگان
چکیده
The interest of scientists for the transcription of the eukaryotic genome started four decades ago with the purification of the three RNA polymerase (Pol) enzymes. Pol I, II and III transcribe different species of RNA with the help of several general/basal transcription factors (TFs). Messenger RNA (mRNA) transcription by Pol II has been intensely studied owing first to the protein-coding function of mRNA and also to the apparent complexity of this system compared to the transcription of ribosomal RNAs by Pol I or small RNAs by Pol III. Indeed, it was shown very early that mRNA transcription required, apart from Pol II, additional enzymatic activities that didn’t seem to be needed in the Pol I or III systems. Surprisingly enough, all these activities reside in TFIIH, a multi-subunit transcription/repair factor that is involved, through its CDK7 and XPB subunits, both in the phosphorylation of the carboxyl-terminal domain of the largest Pol II subunit and in the ATP-dependent opening of the promoter around the transcription start site, respectively [3]. Consequently, the model of promoter opening that has prevailed in class II gene expression during the last four decades suggests that XPB was an ATP-dependent DNA helicase that unwinds promoter DNA from -8 to +2, relative to the transcription start site (Figure 1, former model). Since transcription initiation takes place in the absence of ATP in Pol Iand III dependent transcription, it was expected that these enzymes used different molecular mechanisms to open their promoters, using the energy generated during the formation of their PIC. Recent results contradicted the above Pol II model and have deeply modified our view of transcription initiation in eukaryotes. First of all, in contrast to its ATPase activity that is robust, the in vitro helicase activity of XPB appeared very low [3]. Rather, XPB showed the structural and biochemical characteristics of a translocase, able to move along the double stranded DNA without unwinding it [3]. Moreover, technical advances in our capacity to localize transcription factors inside the preinitiation complex (PIC) have revealed that XPB was binding to the promoter DNA downstream from the transcription start site, a location that was not compatible with its role in promoter opening [3]. In addition, recent structural studies revealed that the Pol I and III machineries contained a core that was structurally and functionally conserved in the Pol II initiation complex, pinpointing to a possible convergence of the three systems to a single mechanism of transcription initiation [8]. The final blow to the canonical model of helicase-dependent mechanism of class II promoter opening came from the discovery that Pol II-dependent transcription was sensitive to the inhibition of XPB ATPase activity but accommodated to the absence of the protein [1]. These observations, seemingly contradictory, become meaningful when one takes into consideration the current knowledge about transcription initiation described above. Indeed, they all converge to a model in which XPB initially acts as an inhibitor of promoter opening, blocking the ATPindependent unwinding of the promoter generated by the formation of the PIC. In a second step, XPB uses ATP to translocate along the double stranded DNA downstream from the transcription start site. This movement liberates the promoter and allows its helicase-free Pol I/III-like opening (Figure 1). This model implies that Pol I, II and III do not differ mechanistically from each other on the way promoters are opened but rather on the presence of a regulatory step in Pol II-dependent transcription that controls in time and space promoter opening after the formation of the PIC. The new regulatory step described above depends on the ATPase activity of XPB and is probably the target of the very promising anti-cancer compound Minnelide. This small molecule is a synthetic prodrug of Triptolide, a diterpenoid epoxide endogenously produced by the thunder god vine, tripterygium wilfordii, which binds XPB Editorial
منابع مشابه
Cloning and secretory expression of VP2 gene of infectious bursal disease virus in eukaryotic cells
VP2 gene coding region of a vaccinal strain (D78) of infectious bursal disease virus (IBDV) was clonedin a eukaryotic expression vector, pSec Tag2A. The gene was placed downstream of Ig κ chain leadersequence, under the control of human cytomegalovirus (hCMV) immediate early enhancer and promoter. Theconstruct pSec Tag2A-VP2 was transfected in COS-7 cell line and the expression and secretion of...
متن کاملCloning and Expression of VP2 Gene of Infectious Bursal Disease Virus in Eukaryotic Cells
Infectious bursal disease (IBD) is an economically important viral disease of chickens with worldwide distribution which suppresses the immune system of young chickens. VP2 is the major host-protective protein of infectious bursal disease virus (IBDV). The encoding region of VP2 protein was PCR amplified from a plasmid containing a cDNA fragment of large genomic segment of IBDV, strain D78. Thi...
متن کاملCLONING AND EXPRESSION OF A HUMAN INTERFERON a2 GENE IN E. COLI
The plasmid pALCA1SIFN containing cDNA that encodes the human interferon a-2b was obtained from the ATCC(no. 531667). In this system the expression of the gene is under the control of an alcA promoter. alcA p is a specific promoter for expression of different genes in Aspergillusfilamentous. In this plasmid the coding region of IFN?-2b is preceded by the coding region of a synthetic signal ...
متن کاملCloning and high level expression of bovine interferon gamma gene in eukaryotic cells (COS-7)
Interferon gamma (IFN-γ) is one of the key cytokines in defining T helper 1 lymphocyte immuneresponses. In this study, the bovine IFN-γ gene was cloned from spleen tissue RNA using the reversetranscription-polymerase chain reaction (RT-PCR). IFN-γ cDNA was sub-cloned and expressed inmammalian expression plasmid (pcDNA3.1(+)) under the control of the human cytomegalovirus (CMV)promoter. The pred...
متن کاملتولید هورمون رشد انسانی نوترکیب توسط سلول تخمدان هامستر چینی و بررسی فعالیت زیستی آن به روش سنجش گزارشگر ژنی
Background: Cultivated mammalian cells, because of their capacity for proper protein folding, assembly and post–translational modification, have become the dominant system for production of recombinant proteins in clinical application. Therefore, the quality and efficacy of protein can be superior when expressed in mammalian cells compared to other hosts such as bacteria. Gene reporte...
متن کاملDesigning an Engineered Construct Gene Sensitive to Carbohydrate In-vitro and Candidate for Human Insulin Gene Therapy In-vivo
Background and Aim: Diabetes is a common disorder worldwide, and exhaustive efforts have been made to cure this disease. Gene therapy has considered as a potential curative method that has more stability in comparison with the other pharmaceutical methods. However, the application of gene therapy as a definitive treatment demands further investigation. This study aim is to prepare a suitable hi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 8 شماره
صفحات -
تاریخ انتشار 2017